Hepatitis C seroconversion in methadone maintenance treatment programs in Wuhan, China

E-ISSN： 1360-0443|110|5|796-802

ISSN： 0965-2140

Source： ADDICTION, Vol.110, Iss.5, 2015-05, pp. : 796-802

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Commentary on Zhou et al. (2015): Research on methadone maintenance treatment (MMT) as prevention for HCV infection ‐ MMT is not a single variable

ADDICTION, Vol. 110, Iss. 5, 2015-05 ,pp. : 803-804

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hepatitis C virus treatment as prevention among injecting drug users: who should we cure first?

ADDICTION, Vol. 110, Iss. 6, 2015-06 ,pp. : 975-983

John Wiley & Sons Inc

Access to resources Recommend Favorite

The changing landscape of hepatitis C treatment—not ‘can we cure?’ but ‘who should we cure first?’ Is this an ethical approach?

ADDICTION, Vol. 110, Iss. 6, 2015-06 ,pp. : 984-985

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treating substance use disorders in patients with hepatitis C

ADDICTION, Vol. 110, Iss. 7, 2015-07 ,pp. : 1057-1059

John Wiley & Sons Inc

Access to resources Recommend Favorite

A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia

ADDICTION, Vol. 110, Iss. 4, 2015-04 ,pp. : 646-655

John Wiley & Sons Inc

Access to resources Recommend Favorite